182 related articles for article (PubMed ID: 2115753)
1. Screening for cervical cancer.
Eddy DM
Ann Intern Med; 1990 Aug; 113(3):214-26. PubMed ID: 2115753
[TBL] [Abstract][Full Text] [Related]
2. Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) on the incidence of invasive cervical cancer.
Helfand M; O'Connor GT; Zimmer-Gembeck M; Beck JR
Med Care; 1992 Dec; 30(12):1067-82. PubMed ID: 1453813
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of cervical-vaginal rescreening.
Raab SS
Am J Clin Pathol; 1997 Nov; 108(5):525-36. PubMed ID: 9353091
[TBL] [Abstract][Full Text] [Related]
4. Papanicolaou cervical smears for screening in asymptomatic women.
Barnes BA
Prim Care; 1981 Mar; 8(1):131-40. PubMed ID: 6911755
[TBL] [Abstract][Full Text] [Related]
5. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
Hutchinson ML; Berger BM; Farber FL
Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cervical cytology.
McCrory DC; Matchar DB; Bastian L; Datta S; Hasselblad V; Hickey J; Myers E; Nanda K
Evid Rep Technol Assess (Summ); 1999 Jan; (5):1-6. PubMed ID: 11925972
[No Abstract] [Full Text] [Related]
7. Does cervical cancer screening do more harm than good?
Payne L; Lavis P
Nurs Times; 2001 Jul 19-25; 97(29):20. PubMed ID: 11957496
[No Abstract] [Full Text] [Related]
8. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of cervical cancer screening: comparison of screening policies.
van den Akker-van Marle ME; van Ballegooijen M; van Oortmarssen GJ; Boer R; Habbema JD
J Natl Cancer Inst; 2002 Feb; 94(3):193-204. PubMed ID: 11830609
[TBL] [Abstract][Full Text] [Related]
10. [Cost effectiveness analysis of screening strategies for cervical cancer in Tunisia].
Lazaar HB; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
East Mediterr Health J; 2010 Jun; 16(6):602-8. PubMed ID: 20799586
[TBL] [Abstract][Full Text] [Related]
11. A decade has passed...the Pap smear and cervical cancer.
Linder J
Am J Clin Pathol; 1997 Nov; 108(5):492-8. PubMed ID: 9353086
[No Abstract] [Full Text] [Related]
12. Cost-effective policies for cervical cancer screening. An international review.
Fahs MC; Plichta SB; Mandelblatt JS
Pharmacoeconomics; 1996 Mar; 9(3):211-30. PubMed ID: 10160098
[TBL] [Abstract][Full Text] [Related]
13. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.
Goldie SJ; Kohli M; Grima D; Weinstein MC; Wright TC; Bosch FX; Franco E
J Natl Cancer Inst; 2004 Apr; 96(8):604-15. PubMed ID: 15100338
[TBL] [Abstract][Full Text] [Related]
14. Does the increased sensitivity of the new Papanicolaou (Pap) tests improve the cost-effectiveness of screening for cervical cancer?
Reust CE
J Fam Pract; 2001 Feb; 50(2):175. PubMed ID: 11219567
[No Abstract] [Full Text] [Related]
15. Costs and benefits of cervical screening. II. Is it worthwhile reducing the screening interval from 5 to 3 years?
Waugh N; Robertson A
Cytopathology; 1996 Aug; 7(4):241-8. PubMed ID: 8853970
[TBL] [Abstract][Full Text] [Related]
16. Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness.
van Ballegooijen M; van den Akker-van Marle ME; Warmerdam PG; Meijer CJ; Walboomers JM; Habbema JD
Br J Cancer; 1997; 76(5):651-7. PubMed ID: 9303366
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
Kim JJ; Leung GM; Woo PP; Goldie SJ
J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
[TBL] [Abstract][Full Text] [Related]
18. Pitfalls in the screening and early diagnosis of cervical cancer.
Wain GV; Hacker NF
Curr Opin Obstet Gynecol; 1990 Feb; 2(1):74-9. PubMed ID: 2102310
[No Abstract] [Full Text] [Related]
19. Cost-effective analysis of mass screening for cervical cancer in Japan.
Matsunaga G; Tsuji I; Sato S; Fukao A; Hisamichi S; Yajima A
J Epidemiol; 1997 Sep; 7(3):135-41. PubMed ID: 9337511
[TBL] [Abstract][Full Text] [Related]
20. Assessment of cervical cancer screening and follow-up programs.
Celentano DD; deLissovoy G
Public Health Rev; 1989-1990; 17(2-3):173-240. PubMed ID: 2518819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
